ARG-007 Shows Significant Neuroprotection in Main TBI Study
Released 03 Feb 25
Latest announcements
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this announcement.